Skip to content

Innovative method of Alopecia treatment by using adipose-derived stromal vascular fraction (SVF) cells

Effectiveness assessment of autologous adipose tissue derived stromal vascular fraction(SVF) on alopecia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0005880
Enrollment
20
Registered
2021-02-09
Start date
2021-02-17
Completion date
Unknown
Last updated
2021-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

TOP Cell Plastic Surgery
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Male and female patients with androgenic alopecia 2. Age of 20-65 years, provide written informed consent and comply with the study requirements 3. Norwood-Hamilton grades I-V 4. Active hair loss within last 12 months 5. No clinically significant disease or abnormal laboratory results at the time of screening visit 6. Patient has adequate abdominal or other subcutaneous adipose tissue accessible by syringe-based lipoharvest 7. For women of child-bearing potential: negative pregnancy test at screening visit

Exclusion criteria

Exclusion criteria: 1. Patients with inflammation, infection, malignancy, allegoric disease, autoimmune disease, pregnancy, diabetes and on current anticoagulant therapy. 2. Subject who has previously failed or has been deemed nonresponsive to a previous experimental hair loss treatment, prior surgery in the treatment area and subject who has a sensitive, irritated, or abraded scalp area 3. Clinically significant medical or psychiatric illness currently or within 30 days of study screening as determined by the investigator 4. Any disease or condition (medical or surgical) that in the opinion of the investigator, might compromise hematologic, cardiovascular, pulmonary, renal, gastrointestinal, hepatic, or central nervous system function; or any condition that would place the subject at increased risk

Design outcomes

Primary

MeasureTime frame
Alopecia grede, Hair density, Hair thickness

Secondary

MeasureTime frame
scalp status, keratin of scalp, scalp sensitivity, scalp sebum, hair pore status, and cuticle status

Countries

Korea, Republic of

Contacts

Public ContactSung ILL Chung

TOP Cell Plastic Surgery

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026